Scalper1 News
Big pharma AbbVie (ABBV) raised its 2014 earnings guidance Monday, sending the company’s stock up 1.5% in morning trading on the stock market. Meanwhile, AbbVie’s buyout target Shire (SHPG) detailed its own bullish guidance in explaining to investors why it is worth more than the $46.5 billion AbbVie offered last week. AbbVie added six cents to its full-year EPS range, now $3.06 to $3.16. Analysts have modeled $3.14, which would be flat with the Scalper1 News
Scalper1 News